Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Sysmex ( (JP:6869) ) just unveiled an update.
Sysmex Corporation announced a slight deviation from its financial forecast for the fiscal year ending March 31, 2025, with actual results showing a minor shortfall in net sales and profits due to weaker performance in certain regions despite strong sales in the Americas and Japan. The company also declared a year-end dividend of ¥17 per share, resulting in a total annual dividend of ¥32 per share, reflecting a consolidated payout ratio of 37.4%, aligning with its policy of stable shareholder returns.
The most recent analyst rating on (JP:6869) stock is a Buy with a Yen3500.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.
More about Sysmex
Sysmex Corporation, headquartered in Kobe, Japan, operates in the healthcare industry, specializing in diagnostic testing instruments and reagents. The company focuses on providing innovative solutions for clinical laboratory testing, particularly in hematology, urinalysis, and hemostasis.
Average Trading Volume: 1,229,012
Technical Sentiment Signal: Sell
Current Market Cap: Yen1646.3B
For a thorough assessment of 6869 stock, go to TipRanks’ Stock Analysis page.